Kieran Gallahue, Director at Edwards Lifesciences Corp (EW), bought 3,000 shares at $84.63 ($254K) on 2016-11-29, disclosed to the SEC on 2016-12-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| EW | BUY | 2017-02-06 | $270K | — | Filing → |
| XENT | BUY | 2016-05-17 | $101K | — | Filing → |
| CFN | SELL | 2014-05-20 | $4.3M | — | Filing → |